Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
Congenital myasthenic syndromes due to DOK7 mutations cause fatigable limb girdle weakness. Treatment with ephedrine improves muscle strength. Salbutamol, a β(2)-adrenergic receptor agonist with fewer side effects and more readily available, has been effective in adult and anecdotal childhood cases....
主要な著者: | , , , , , , , , , , |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2013
|